SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TURN, RDFN, AMPY, HEES on Behalf of Shareholders

Stock Information for Lineage Cell Therapeutics, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lineage Cell Therapeutics, Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MHLD, TURN, FNA, PTMN on Behalf of Shareholders
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating The Merger - SLRN, TURN, BHLB, MHLD
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - SLRN, TURN, BHLB, MHLD
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, TURN, AMPY on Behalf of Shareholders
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of 180 Degree Capital Corp. (TURN)
180 Degree Capital Corp. Notes Filing of Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc. and Provides Interim Update on Developments in Q1 2025
Mount Logan Capital Inc. Announces Fourth Quarter and Fiscal 2024 Financial Results
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq - TURN)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.